Jasper Therapeutics, Inc.

NASDAQ:JSPR

22.74 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 106.819118.47586.887103.867115.812129.438.2550.9560.81470.484.701100.9050.310.59119.8380.7580.914-27.1630
Short Term Investments 0000000000000000054.326100.155
Cash and Short Term Investments 106.819118.47586.887103.867115.812129.438.2550.9560.81470.484.701100.9050.310.59119.8380.7580.91427.163100.155
Net Receivables 0.250.250.250.2680.330.250.6630.3840.4430.5630.6980.298000.60000
Inventory 0000.6721.7721.8670-0.3842.0022.809-0.6981.1940000000
Other Current Assets 1.6111.5831.8010.4110.6530.9912.8181.4610.0270.0270.0210.010.1130.1660.2470.2060.2670.3260
Total Current Assets 108.68120.30888.938105.218118.567132.50841.73152.41163.28673.79987.831102.4070.4230.75720.6850.9641.18127.163100.155
Non-Current Assets:
Property, Plant & Equipment, Net 3.6693.8154.1944.3594.7415.1075.4545.7396.0865.7214.8334.4614.0473.6462.0290000
Goodwill 0000000000000000000
Intangible Assets 0000000000000000000
Goodwill and Intangible Assets 00-0000-0.98000-0.66800000000
Long Term Investments 0.4170.4170.4170.4170.4170.4170.4170.4170.4170.4170.3450.345100.126100.20400000
Tax Assets 000.4880000.5630000.32300000000
Other Non-Current Assets 1.1631.4231.3430.4110.4450.7251.1760.5430.5770.6110.990-4.047-3.6460.643100.355100.416-27.1630
Total Non-Current Assets 5.2495.6556.4425.1875.6036.2496.636.6997.086.7495.8234.806100.126100.2042.672100.355100.416-27.1630
Total Assets 113.929125.96395.38110.405124.17138.75748.36159.1170.36680.54893.654107.213100.549100.9623.357101.318101.597101.694100.155
Liabilities & Equity:
Current Liabilities:
Account Payables 2.9642.3914.1493.2561.5813.8461.7683.1172.9971.4663.9192.2474.6121.351.4170000
Short Term Debt 1.02910.9720.9450.9170.8910.8650.840.7840.5210.5050.490000000
Tax Payables 0000000000.105000.010.0050.0050.0080.0730.0160
Deferred Revenue 0007.2856.085000002.8115.5520000000
Other Current Liabilities 6.0755.5257.2530.420.3893.1554.4323.4642.8413.9820.7850.87-4.283-1.1692.5950.180.2580.1110
Total Current Liabilities 10.0688.91612.37411.9068.9727.8927.0657.4216.6225.9698.029.1590.3290.1814.0120.180.2580.1110
Non-Current Liabilities:
Long Term Debt 1.2871.5531.8142.0692.3172.5542.7863.0143.2343.3832.382.5122.6422.6841.6240000
Deferred Revenue Non-Current 00-2.264000-0.563000-0.32300000000
Deferred Tax Liabilities Non-Current 000.4880000.5630000.32300000000
Other Non-Current Liabilities 0-02.2642.2972.6763.1132.5211.111.7293.09113.73616.9411.2888.23652.8513.53.53.50
Total Non-Current Liabilities 1.2871.5532.3024.3664.9935.6675.3074.1244.9636.47416.11619.45213.9310.9254.4753.53.53.50
Total Liabilities 11.35510.46914.67616.27213.96513.55912.37211.54511.58512.44324.13628.61114.25911.10158.4873.683.7583.6110
Equity:
Preferred Stock 00000000000107.21366.24966.24943.840025.8360
Common Stock 0.0020.0020.0010.0110.0110.0110.0040.0040.0040.0040.0040.00481.29184.860.00192.63892.83993.0830
Retained Earnings -197.911-183.328-169.6-153.019-135.475-119.395-105.135-91.924-80.061-69.657-67.45-58.393-5.149-1.579-36.813-0.442-0.2410.0020
Accumulated Other Comprehensive Income/Loss 0000-00000-00-107.2130-151.109-43.8400-4.7340
Other Total Stockholders Equity 298.219296.556248.039247.141245.669244.582141.12139.485138.838137.758136.964136.991-56.10191.4391.682-87.196-87.598-93.0850
Total Shareholders Equity 100.31113.2378.4494.133110.205125.19835.98947.56558.78168.10569.51878.60286.2989.86-35.135521.1020
Total Equity 100.31113.2378.4494.133110.205125.19835.98947.56558.78168.10569.51878.60286.2989.86-35.135521.1020
Total Liabilities & Shareholders Equity 113.929125.96395.38110.405124.17138.75748.36159.1170.36680.54893.654107.213100.549100.9623.357101.318101.59721.102100.155